{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:48:31Z","timestamp":1777654111125,"version":"3.51.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T00:00:00Z","timestamp":1618963200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MOP-136854"],"award-info":[{"award-number":["MOP-136854"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1007\/s40266-021-00859-1","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T02:02:25Z","timestamp":1618970545000},"page":"611-623","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Trends in Anticoagulant Use at Nursing Home Admission and Variation by Frailty and Chronic Kidney Disease Among Older Adults with Atrial Fibrillation"],"prefix":"10.1007","volume":"38","author":[{"given":"Michael A.","family":"Campitelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan E.","family":"Bronskill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anjie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura C.","family":"Maclagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clare L.","family":"Atzema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate L.","family":"Lapane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel A.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7988-2899","authenticated-orcid":false,"given":"Colleen J.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,21]]},"reference":[{"issue":"8","key":"859_CR1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1161\/01.STR.22.8.983","volume":"22","author":"PA Wolf","year":"1991","unstructured":"Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the framingham study. Stroke. 1991;22(8):983\u20138.","journal-title":"Stroke"},{"issue":"6","key":"859_CR2","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1161\/01.STR.0000166053.83476.4a","volume":"36","author":"C Marini","year":"2005","unstructured":"Marini C, De Santis F, Sacco S, Russo T, Olivieri L, Totaro R, et al. Contribution of atrial fibrillation to incidence and outcome of ischemic stroke: results from a population-based study. Stroke. 2005;36(6):1115\u20139.","journal-title":"Stroke"},{"issue":"10","key":"859_CR3","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","volume":"27","author":"HJ Lin","year":"1996","unstructured":"Lin HJ, Wolf PA, Kelly-Hayes M, Beiser AS, Kase CS, Benjamin EJ, et al. Stroke severity in atrial fibrillation. The Framingham study. Stroke. 1996;27(10):1760\u20134.","journal-title":"Stroke"},{"issue":"11","key":"859_CR4","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.cjca.2018.08.026","volume":"34","author":"JG Andrade","year":"2018","unstructured":"Andrade JG, Verma A, Mitchell LB, Parkash R, Leblanc K, Atzema C, et al. 2018 focused update of the Canadian cardiovascular society guidelines for the management of atrial fibrillation. Can J Cardiol. 2018;34(11):1371\u201392.","journal-title":"Can J Cardiol."},{"issue":"2","key":"859_CR5","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1161\/CIR.0000000000000665","volume":"140","author":"CT January","year":"2019","unstructured":"January CT, Wann LS, Calkins H, Chen LY, Cigarroa JE, Cleveland JC Jr, et al. 2019 AHA\/ACC\/HRS focused update of the 2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines and the heart rhythm society in collaboration with the Society of Thoracic Surgeons. Circulation. 2019;140(2):e125\u201351.","journal-title":"Circulation"},{"issue":"12","key":"859_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.7326\/0003-4819-146-12-200706190-00007","volume":"146","author":"RG Hart","year":"2007","unstructured":"Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146(12):857\u201367.","journal-title":"Ann Intern Med."},{"issue":"12","key":"859_CR7","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1016\/j.amjmed.2015.05.044","volume":"128","author":"GD Barnes","year":"2015","unstructured":"Barnes GD, Lucas E, Alexander GC, Goldberger ZD. National trends in ambulatory oral anticoagulant use. Am J Med. 2015;128(12):1300-5.e2.","journal-title":"Am J Med."},{"issue":"2","key":"859_CR8","first-page":"68","volume":"13","author":"L Gao","year":"2017","unstructured":"Gao L, Tadrous M, Knowles S, Mamdani M, Paterson JM, Juurlink D, et al. Prior authorization and canadian public utilization of direct-acting oral anticoagulants. Healthc Policy. 2017;13(2):68\u201378.","journal-title":"Healthc Policy."},{"issue":"18","key":"859_CR9","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","volume":"285","author":"AS Go","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the anticoagulation and risk factors in atrial fibrillation (atria) study. JAMA. 2001;285(18):2370\u20135.","journal-title":"JAMA"},{"issue":"5","key":"859_CR10","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.ijcard.2012.12.093","volume":"167","author":"J Ball","year":"2013","unstructured":"Ball J, Carrington MJ, McMurray JJ, Stewart S. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century. Int J Cardiol. 2013;167(5):1807\u201324.","journal-title":"Int J Cardiol."},{"key":"859_CR11","first-page":"15","volume":"4","author":"M Alcusky","year":"2018","unstructured":"Alcusky M, Lapane KL. Treatment of atrial fibrillation in nursing homes: a place for direct acting oral anticoagulants? J Nurs Home Res Sci. 2018;4:15\u20139.","journal-title":"J Nurs Home Res Sci."},{"issue":"6","key":"859_CR12","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.jamda.2012.03.007","volume":"13","author":"G Reardon","year":"2012","unstructured":"Reardon G, Nelson WW, Patel AA, Philpot T, Neidecker M. Prevalence of atrial fibrillation in us nursing homes: results from the national nursing home survey, 1985\u20132004. J Am Med Dir Assoc. 2012;13(6):529\u201334.","journal-title":"J Am Med Dir Assoc."},{"issue":"11","key":"859_CR13","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1016\/j.jamda.2018.07.020","volume":"19","author":"LC Maclagan","year":"2018","unstructured":"Maclagan LC, Bronskill SE, Guan J, Campitelli MA, Herrmann N, Lapane KL, et al. Predictors of cholinesterase discontinuation during the first year after nursing home admission. J Am Med Dir Assoc. 2018;19(11):959-66 e4.","journal-title":"J Am Med Dir Assoc."},{"issue":"9","key":"859_CR14","doi-asserted-by":"publisher","first-page":"e012023","DOI":"10.1161\/JAHA.119.012023","volume":"8","author":"M Alcusky","year":"2019","unstructured":"Alcusky M, McManus DD, Hume AL, Fisher M, Tjia J, Lapane KL. Changes in anticoagulant utilization among United States nursing home residents with atrial fibrillation from 2011 to 2016. J Am Heart Assoc. 2019;8(9):e012023.","journal-title":"J Am Heart Assoc."},{"issue":"10","key":"859_CR15","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1111\/jgs.15016","volume":"65","author":"LC Maclagan","year":"2017","unstructured":"Maclagan LC, Maxwell CJ, Gandhi S, Guan J, Bell CM, Hogan DB, et al. Frailty and potentially inappropriate medication use at nursing home transition. J Am Geriatr Soc. 2017;65(10):2205\u201312.","journal-title":"J Am Geriatr Soc."},{"issue":"9","key":"859_CR16","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1111\/jgs.15013","volume":"65","author":"MA Campitelli","year":"2017","unstructured":"Campitelli MA, Maxwell CJ, Giannakeas V, Bell CM, Daneman N, Jeffs L, et al. The variation of statin use among nursing home residents and physicians: a cross-sectional analysis. J Am Geriatr Soc. 2017;65(9):2044\u201351.","journal-title":"J Am Geriatr Soc."},{"issue":"25","key":"859_CR17","doi-asserted-by":"publisher","first-page":"E851","DOI":"10.1503\/cmaj.161437","volume":"189","author":"N Daneman","year":"2017","unstructured":"Daneman N, Campitelli MA, Giannakeas V, Morris AM, Bell CM, Maxwell CJ, et al. Influences on the start, selection and duration of treatment with antibiotics in long-term care facilities. CMAJ. 2017;189(25):E851\u201360.","journal-title":"CMAJ"},{"issue":"12","key":"859_CR18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1016\/j.cjca.2016.06.006","volume":"32","author":"K Tu","year":"2016","unstructured":"Tu K, Nieuwlaat R, Cheng SY, Wing L, Ivers N, Atzema CL, et al. Identifying patients with atrial fibrillation in administrative data. Can J Cardiol. 2016;32(12):1561\u20135.","journal-title":"Can J Cardiol."},{"issue":"8","key":"859_CR19","doi-asserted-by":"publisher","first-page":"e008643","DOI":"10.1161\/JAHA.118.008643","volume":"7","author":"BK Martinez","year":"2018","unstructured":"Martinez BK, Sood NA, Bunz TJ, Coleman CI. Effectiveness and safety of apixaban, dabigatran, and rivaroxaban versus warfarin in frail patients with nonvalvular atrial fibrillation. J Am Heart Assoc. 2018;7(8):e008643.","journal-title":"J Am Heart Assoc."},{"key":"859_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/s12877-016-0309-z","volume":"16","author":"MA Campitelli","year":"2016","unstructured":"Campitelli MA, Bronskill SE, Hogan DB, Diong C, Amuah JE, Gill S, et al. The prevalence and health consequences of frailty in a population-based older home care cohort: a comparison of different measures. BMC Geriatr. 2016;16:133.","journal-title":"BMC Geriatr."},{"key":"859_CR21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1471-2369-14-81","volume":"14","author":"JL Fleet","year":"2013","unstructured":"Fleet JL, Dixon SN, Shariff SZ, Quinn RR, Nash DM, Harel Z, et al. Detecting chronic kidney disease in population-based administrative databases using an algorithm of hospital encounter and physician claim codes. BMC Nephrol. 2013;14:81.","journal-title":"BMC Nephrol."},{"issue":"4","key":"859_CR22","doi-asserted-by":"publisher","first-page":"M174","DOI":"10.1093\/geronj\/49.4.M174","volume":"49","author":"JN Morris","year":"1994","unstructured":"Morris JN, Fries BE, Mehr DR, Hawes C, Phillips C, Mor V, et al. Mds cognitive performance scale. J Gerontol. 1994;49(4):M174\u201382.","journal-title":"J Gerontol."},{"issue":"2","key":"859_CR23","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","volume":"137","author":"GY Lip","year":"2010","unstructured":"Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest. 2010;137(2):263\u201372.","journal-title":"Chest"},{"issue":"25","key":"859_CR24","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1002\/sim.3697","volume":"28","author":"PC Austin","year":"2009","unstructured":"Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009;28(25):3083\u2013107.","journal-title":"Stat Med."},{"issue":"6","key":"859_CR25","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1177\/0962280211427759","volume":"22","author":"GY Zou","year":"2013","unstructured":"Zou GY, Donner A. Extension of the modified poisson regression model to prospective studies with correlated binary data. Stat Methods Med Res. 2013;22(6):661\u201370.","journal-title":"Stat Methods Med Res."},{"issue":"6","key":"859_CR26","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40266-013-0067-y","volume":"30","author":"G Reardon","year":"2013","unstructured":"Reardon G, Nelson WW, Patel AA, Philpot T, Neidecker M. Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding risk. Drugs Aging. 2013;30(6):417\u201328.","journal-title":"Drugs Aging."},{"issue":"1","key":"859_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/jgs.13200","volume":"63","author":"O Bahri","year":"2015","unstructured":"Bahri O, Roca F, Lechani T, Druesne L, Jouanny P, Serot JM, et al. Underuse of oral anticoagulation for individuals with atrial fibrillation in a nursing home setting in France: comparisons of resident characteristics and physician attitude. J Am Geriatr Soc. 2015;63(1):71\u20136.","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"859_CR28","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1111\/bcp.13474","volume":"84","author":"K Jobski","year":"2018","unstructured":"Jobski K, Hoffmann F, Herget-Rosenthal S, Dorks M. Use of oral anticoagulants in German nursing home residents: drug use patterns and predictors for treatment choice. Br J Clin Pharmacol. 2018;84(3):590\u2013601.","journal-title":"Br J Clin Pharmacol."},{"issue":"8","key":"859_CR29","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/clc.23196","volume":"42","author":"V Aursulesei","year":"2019","unstructured":"Aursulesei V, Costache II. Anticoagulation in chronic kidney disease: from guidelines to clinical practice. Clin Cardiol. 2019;42(8):774\u201382.","journal-title":"Clin Cardiol."},{"issue":"3","key":"859_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.jacc.2018.04.063","volume":"72","author":"AP Kent","year":"2018","unstructured":"Kent AP, Brueckmann M, Fraessdorf M, Connolly SJ, Yusuf S, Eikelboom JW, et al. Concomitant oral anticoagulant and nonsteroidal anti-inflammatory drug therapy in patients with atrial fibrillation. J Am Coll Cardiol. 2018;72(3):255\u201367.","journal-title":"J Am Coll Cardiol."},{"issue":"5","key":"859_CR31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/CIRCULATIONAHA.112.115386","volume":"127","author":"AL Dans","year":"2013","unstructured":"Dans AL, Connolly SJ, Wallentin L, Yang S, Nakamya J, Brueckmann M, et al. Concomitant use of antiplatelet therapy with dabigatran or warfarin in the randomized evaluation of long-term anticoagulation therapy (re-ly) trial. Circulation. 2013;127(5):634\u201340.","journal-title":"Circulation"},{"issue":"6","key":"859_CR32","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1093\/ageing\/afr097","volume":"40","author":"D Pugh","year":"2011","unstructured":"Pugh D, Pugh J, Mead GE. Attitudes of physicians regarding anticoagulation for atrial fibrillation: a systematic review. Age Ageing. 2011;40(6):675\u201383.","journal-title":"Age Ageing."},{"issue":"4","key":"859_CR33","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1345\/aph.1K498","volume":"42","author":"CL Garwood","year":"2008","unstructured":"Garwood CL, Corbett TL. Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls. Ann Pharmacother. 2008;42(4):523\u201332.","journal-title":"Ann Pharmacother."},{"issue":"3","key":"859_CR34","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.amjcard.2018.04.022","volume":"122","author":"WT O'Neal","year":"2018","unstructured":"O\u2019Neal WT, Sandesara PB, Claxton JS, MacLehose RF, Chen LY, Bengtson LGS, et al. Influence of sociodemographic factors and provider specialty on anticoagulation prescription fill patterns and outcomes in atrial fibrillation. Am J Cardiol. 2018;122(3):388\u201394.","journal-title":"Am J Cardiol."},{"issue":"2","key":"859_CR35","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.cjca.2015.05.012","volume":"32","author":"MC Lefebvre","year":"2016","unstructured":"Lefebvre MC, St-Onge M, Glazer-Cavanagh M, Bell L, Kha Nguyen JN, Viet-Quoc Nguyen P, et al. The effect of bleeding risk and frailty status on anticoagulation patterns in octogenarians with atrial fibrillation: the FRAIL-AF study. Can J Cardiol. 2016;32(2):169\u201376.","journal-title":"Can J Cardiol."},{"issue":"2","key":"859_CR36","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/ageing\/afy180","volume":"48","author":"C Wilkinson","year":"2019","unstructured":"Wilkinson C, Todd O, Clegg A, Gale CP, Hall M. Management of atrial fibrillation for older people with frailty: a systematic review and meta-analysis. Age Ageing. 2019;48(2):196\u2013203.","journal-title":"Age Ageing."},{"key":"859_CR37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.ejim.2018.04.018","volume":"56","author":"ER Villani","year":"2018","unstructured":"Villani ER, Tummolo AM, Palmer K, Gravina EM, Vetrano DL, Bernabei R, et al. Frailty and atrial fibrillation: a systematic review. Eur J Intern Med. 2018;56:33\u20138.","journal-title":"Eur J Intern Med."},{"issue":"1","key":"859_CR38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s40471-020-00226-5","volume":"7","author":"DB Hogan","year":"2020","unstructured":"Hogan DB, Maxwell CJ. Frailty and unintended risks of medications. Curr Epidemiol Rep. 2020;7(1):16\u201324.","journal-title":"Curr Epidemiol Rep."},{"issue":"6","key":"859_CR39","doi-asserted-by":"publisher","first-page":"e007943","DOI":"10.1161\/JAHA.117.007943","volume":"7","author":"WT O'Neal","year":"2018","unstructured":"O\u2019Neal WT, Sandesara PB, Claxton JS, MacLehose RF, Chen LY, Bengtson LGS, et al. Provider specialty, anticoagulation prescription patterns, and stroke risk in atrial fibrillation. J Am Heart Assoc. 2018;7(6):e007943.","journal-title":"J Am Heart Assoc."},{"issue":"8","key":"859_CR40","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1007\/s11606-020-05777-3","volume":"35","author":"M Alcusky","year":"2020","unstructured":"Alcusky M, Tjia J, McManus DD, Hume AL, Fisher M, Lapane KL. Comparative safety and effectiveness of direct-acting oral anticoagulants versus warfarin: a national cohort study of nursing home residents. J Gen Intern Med. 2020;35(8):2329\u201337.","journal-title":"J Gen Intern Med."}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00859-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40266-021-00859-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-021-00859-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T02:07:41Z","timestamp":1625796461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40266-021-00859-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,21]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["859"],"URL":"https:\/\/doi.org\/10.1007\/s40266-021-00859-1","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,21]]},"assertion":[{"value":"2 April 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was funded by the Canadian Institutes of Health Research (CIHR) through an operating grant (Exploring Frailty and its Role in the Assessment of High-Risk Medications and Risk of Poor Health Outcomes in Vulnerable Populations\u2014MOP\u2010136854). This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH)\u00a0and Ministry of Long Term Care (MLTC). The opinions, results, and conclusions reported are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOH or MLTC\u00a0is intended or should be inferred. Parts of this material are based on data and information compiled and provided by the CIHI; however, the analyses, conclusions, opinions, and statements expressed herein are those of the authors, and not necessarily those of the CIHI.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The study sponsors provided the operating costs and infrastructure to support the research. No funding bodies had any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sponsor\u2019s role"}},{"value":"Michael A. Campitelli, Susan E. Bronskill, Anjie Huang, Laura C. Maclagan, Clare L. Atzema, David B. Hogan, Kate L. Lapane, Daniel A. Harris, and Colleen J. Maxwell have no conflicts of interest to report.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained from the University of Waterloo Office of Research Ethics (#30373).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The dataset from this study is held securely in coded form at ICES. While legal data-sharing agreements prohibit ICES from making the dataset publicly available, access may be granted to those who meet prespecified criteria for confidential access, available at  (email: das@ices.on.ca).","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"The full dataset creation plan and underlying analytic code are available from the authors upon request, understanding that the computer programs may rely on coding templates or macros that are unique to ICES and are therefore either inaccessible or may require modification.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"Study concept and design: MC, CM, SB. Acquisition of data: MC, AH. Analysis and interpretation of data: AH, MC, CM, SB, LM, CA, DBH, KL, DH. Drafting of the manuscript: MC, CM. Critical revision of the manuscript for important intellectual content: MC, CM, SB, AH, LM, CA, DBH, KL, DH. All authors provided approval of the final manuscript submitted for consideration and agree to be accountable for all aspects of this work.","order":10,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}